Tower Research Capital LLC (Trc) Kintara Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.14 - $6.8 $654 - $31,769	-4,672 Reduced 13.84%	29,087 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.14 - $0.5 $2,671 - $9,541	19,082 Added 130.01%	33,759 $9,000
Q1 2022 May 12, 2022	BUY	$0.31 - $0.55 $4,549 - $8,072	14,677 New	14,677 $6,000
Q3 2021 Nov 15, 2021	SELL	$0.82 - $2.3 $2,622 - $7,355	-3,198 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.26 - $2.4 $4,029 - $7,675	3,198 New	3,198 $7,000
Q1 2021 May 17, 2021	SELL	$1.32 - $2.74 $10,632 - $22,070	-8,055 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.26 - $1.72 $7,592 - $10,364	6,026 Added 296.99%	8,055 $10,000
Q3 2020 Nov 16, 2020	BUY	$0.63 - $1.7 $1,278 - $3,449	2,029 New	2,029 $3,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.